Fortunately, we’re entering a new era of medicine. Doctors no longer need to serve as the middlemen for interpreting lab results. This new era will b… - Casey Means
" "Fortunately, we’re entering a new era of medicine. Doctors no longer need to serve as the middlemen for interpreting lab results. This new era will benefit patients profoundly. Levels CEO Sam Corcos calls this concept “bio-observability” — the ability to observe your own biology through technologies like wearables, continuous monitors, and direct-to-consumer (DTC) lab testing. Let me be clear: bio-observability is one of the most disruptive trends our health care industry faces. You should not blindly trust your doctor and you should not blindly trust me. You should trust your own body. Your body can “speak” to you through accessible testing and real-time data from wearable sensors that help you understand how individual symptoms are connected to overall metabolic health.
English
Collect this quote
Related quotes. More quotes will automatically load as you scroll down, or you can use the load more buttons.
Additional quotes by Casey Means
If a medication could slash Alzheimer’s risk by 50 percent, it would be front-page news and prescribed to every patient. But this “drug” does exist — it’s walking! Yet less than 16 percent of doctors prescribe movement to their patients, and 85 percent of practitioners report zero training in prescribing exercise.
Liver Enzymes: aspartate transaminase (AST), alanine transaminase (ALT), and gamma-glutamyl transferase (GGT) AST and ALT levels of 17 U/L or less. For GGT, lowest risk for men is less than 25 U/L and women from 14 to 20 U/L. Sources vary slightly, but these are good targets to aim for. Vitamin D 40 to 60 ng/mL Recommended real-time metrics to track: Glucose (continuous glucose monitor) Food (food journal or app) Sleep (quantity, quality, consistency) Activity (steps, number of active minutes per day and week with elevated heart rate) Resting heart rate and heart rate variability
Enhance Your Quote Experience
Enjoy ad-free browsing, unlimited collections, and advanced search features with Premium.
At the start of my residency, the Affordable Care Act (ACA) was passed and all doctors had to get up to speed on the Merit-Based Incentive Payment System (MIPS), a new program under the Quality Payment Program (QPP), where a physician would now receive substantial adjustments to payments from Medicare if they met specific quality-of-care criteria. One would think that “quality” and “merit” in medicine would mean that the patient was actually getting better. But when I dug deep through the MIPS website to find the specific quality metrics for each specialty, I was shocked to see that these quality criteria were primarily based on whether doctors prescribed drugs regularly or did more interventions. Yes, a government incentive program focused less on actual patient outcomes (i.e., Did the patient get healthier?) and more on whether doctors prescribed long-term pharmaceuticals.
Loading...